Generate Biomedicines Stock
Generate Biomedicines is pioneering the field of generative biology with a revolutionary approach to drug development that allows them to program protein-based modalities for the first time.
Sign up for SecondMarket™ to view the market and buy or sell Generate Biomedicines Stock
Buy + SellGenerate Biomedicines Funding
Sign up to gain insights into Generate Biomedicines funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Jan 12, 2024 | Series C | 280.95M | ||
| Nov 23, 2021 | Series B | 373.42M | ||
| Dec 31, 2019 | Series A | 30.10M |
See Generate Biomedicines Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Generate Biomedicines Stock Valuation + Share Prices
View real-time Tape D™ data on Generate Biomedicines stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Generate Biomedicines Management Team
Director
Stephane Bancel
Director
Frances Arnold
Chief Legal Officer and General Counsel
Sean Martin
CEO, Director
Michael Nally
Co-Founder, Chief Technology Officer
Gevorg Grigoryan
Co-Founder, Director
Geoffrey von Maltzahn
Chief Financial Officer
Jason Silvers
Chief People Officer
Beth Grous
Director
Jane Mendillo
Director
Gary P. Pisano
Co-Founder, Chief Innovation Officer
Molly Gibson
Director
Noubar Afeyan
Generate Biomedicines Major Investors
Amgen Ventures
Abu Dhabi Investment Authority (ADIA)
Mirae Asset Financial Group
Banque Pictet
Flagship Pioneering
Alaska Permanent Fund (APFC)
Morningside Venture Investments, Ltd.
Altitude Life Science Ventures
T. Rowe Price Associates, Inc.
Morningside Venture Investments, Ltd.
March Capital
Fidelity Management & Research Company
T. Rowe Price Associates, Inc.
NVIDIA Corporation
ARCH Venture Partners
Learn More About Generate Biomedicines Stock
Buy Generate Biomedicines Stock
01Generate Biomedicines stock does not trade on public stock exchanges. Generate Biomedicines stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Generate Biomedicines stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Generate Biomedicines Stock
02Generate Biomedicines Stock does not trade on public stock exchanges. In order to sell Generate Biomedicines shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Generate Biomedicines Stock Price
03Generate Biomedicines does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Generate Biomedicines share price and other valuable private market data.
Read more about secondary market private company stock prices:
Generate Biomedicines Stock Ticker Symbol
04There is no ticker symbol for Generate Biomedicines stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Generate Biomedicines Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Generate Biomedicines stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Generate Biomedicines Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Generate Biomedicines stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Generate Biomedicines Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Generate Biomedicines IPO
08Generate Biomedicines is a private company and has not had an IPO. There is currently no Generate Biomedicines IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Generate Biomedicines IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Generate Biomedicines Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
